ID   KPMM1
AC   CVCL_9541
SY   KP-MM1
DR   Wikidata; Q54900440
RX   CelloPub=CLPUB00381;
RX   PubMed=8797890;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
RX   CelloPub=CLPUB00381;
RA   Shimazaki C., Ashihara E., Ohkawa K., Goto H., Oku N., Inaba T.,
RA   Ito K., Fujita N., Nakagawa M., Kawa-Ha K.;
RT   "Establishment of myeloma cell line from a patient with aggressive
RT   myeloma.";
RL   Int. J. Hematol. 55 Suppl. 1:242-242(1992).
//
RX   PubMed=8797890; DOI=10.1111/j.1349-7006.1996.tb02108.x; PMCID=PMC5921175;
RA   Tatsumi T., Shimazaki C., Goto H., Araki S.-i., Sudo Y., Yamagata N.,
RA   Ashihara E., Inaba T., Fujita N., Nakagawa M.;
RT   "Expression of adhesion molecules on myeloma cells.";
RL   Jpn. J. Cancer Res. 87:837-842(1996).
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler H.G., Matsuo Y.;
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//